| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 04/08/2008 | CA2253838C Dp and e2f protein nuclear localisation signals and their use |
| 04/08/2008 | CA2169171C New growth/differentiation factor of the tgf-beta family |
| 04/08/2008 | CA2143104C Phagemids coexpressing a surface receptor and a surface heterologous protein |
| 04/08/2008 | CA2124967C Transgenic non-human animals capable of producing heterologous antibodies |
| 04/08/2008 | CA2122732C Multivalent antigen-binding proteins |
| 04/03/2008 | WO2008039818A2 Modified t cell receptors and related materials and methods |
| 04/03/2008 | WO2008039553A1 Soluble il-17rcx4 and methods of using in inflammation |
| 04/03/2008 | WO2008038766A1 Functional peptide having activity of stimulating immune cell |
| 04/03/2008 | WO2008038024A1 Altered antibodies |
| 04/03/2008 | WO2008038022A1 Test for h. pylori infection |
| 04/03/2008 | WO2008037792A1 Novel antigens and antibodies associated to pancreatic ductal adenocarcinoma |
| 04/03/2008 | WO2008037419A1 Antibodies against ccr5 and uses thereof |
| 04/03/2008 | WO2008019379A3 Use of allogeneic effector cells and anti-cs1 antibodies for selective killing of multiple myeloma cells |
| 04/03/2008 | WO2008019290A3 Human antibodies to erbb 2 |
| 04/03/2008 | WO2007145956A3 USE OF TGF-β ANTAGONISTS IN TREATMENT OF PARATHYROID-RELATED DISORDERS |
| 04/03/2008 | WO2007144046A3 Agent for the treatment of malignant diseases |
| 04/03/2008 | WO2007133811A3 Cd47 related compositions and methods for treating immunological diseases and disorders |
| 04/03/2008 | WO2007130302A3 Rage fusion proteins, formulations, and methods of use thereof |
| 04/03/2008 | WO2007126876A3 Anti-igf-ir antibodies and uses thereof |
| 04/03/2008 | WO2007126799A3 Compositions and methods of use for antibodies of c-met |
| 04/03/2008 | WO2007115045A3 Diagnostics and treatments for tumors |
| 04/03/2008 | WO2007100789A3 Gpat3 encodes a mammalian, microsomal acyl-coa:glycerol 3-phosphate acyltransferase |
| 04/03/2008 | WO2007081447A3 Norovirus and sapovirus antigens |
| 04/03/2008 | US20080081903 Method for screening transcriptional coregulatory proteins of transcription factors, and androgen receptor transcriptional coregulatory proteins as targets for androgen receptor-dependent diseases |
| 04/03/2008 | US20080081841 Materials and Methods for Modulating Cell Motility |
| 04/03/2008 | US20080081794 Smg-1 binding protein and screening method for substances that can regulate the activity thereof |
| 04/03/2008 | US20080081337 Using beta -cell specific insulin gene transcription factor (MafA) as diagnostic tool for identifying insulin producing cells |
| 04/03/2008 | US20080081334 Methods for diagnosis and pronostic of psychiatric diseases |
| 04/03/2008 | US20080081047 severe acute respiratory syndrome; preparing a chimeric antibody; Monoclonal antibody reagents that recognize the SARS-coronavirus (SARS-HCoV) |
| 04/03/2008 | US20080081043 Nucleotide sequences coding natural killer cell ligand for use as tool in treatment cell proliferative disorders |
| 04/03/2008 | US20080081042 Passive Immunization and methods of treament for anthrax using antibodies |
| 04/03/2008 | US20080081040 Using monclonal antibody for treatment and prevention of discomfort associated with cell proliferative disorders |
| 04/03/2008 | US20080081038 Immunoglobulin fusion for prevention and treatment of cell proliferative disorders |
| 04/03/2008 | CA2664841A1 Novel antigens and antibodies associated to pancreatic ductal adenocarcinoma |
| 04/03/2008 | CA2664752A1 Antibodies against ccr5 and uses thereof |
| 04/03/2008 | CA2664740A1 Combination treatment of cd38-expressing tumors |
| 04/03/2008 | CA2663892A1 Stabilized antibody formulations and uses thereof |
| 04/03/2008 | CA2663243A1 Junctional adhesion molecule-c (jam-c) binding compounds and methods of their use |
| 04/03/2008 | CA2638819A1 Soluble il-17rcx4 and methods of using in inflammation |
| 04/02/2008 | EP1906184A1 Diagnostic agent and therapeutic agent for disease related to macrocyte and macrophage |
| 04/02/2008 | EP1905834A2 Virulence Genes, Proteins, and their Use |
| 04/02/2008 | EP1905832A2 Mammalian interleukin-12 P40 and interleukin B30, combinations thereof, antibodies, uses in pharmaceutical compositions |
| 04/02/2008 | EP1905830A1 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| 04/02/2008 | EP1905782A1 Monoclonal and chimeric antibodies specific for human tumor necrosis factor |
| 04/02/2008 | EP1904531A2 Novel madcam antibodies |
| 04/02/2008 | EP1904530A2 Anti-ctla-4 antibody and cpg-motif-containing synthetic oligodeoxynucleotide combination therapy for cancer treatment |
| 04/02/2008 | EP1904527A2 Identification of a novel bitter taste receptor t2r76 that specifically responds to brucine and prop bitter ligands |
| 04/02/2008 | EP1904104A2 Sp35 antibodies and uses thereof |
| 04/02/2008 | EP1904103A2 Use of anti-madcam antibodies for the treatment of coeliac disease and tropical sprue |
| 04/02/2008 | EP1904095A1 Treatment of liver cirrhosis and its complications |
| 04/02/2008 | EP1904088A2 Compositions and methods for the treatment of cancer |
| 04/02/2008 | EP1327680B1 Modified tpo agonist antibody |
| 04/02/2008 | EP1244466B1 ACTIVATION OF THE IMMUNE SYSTEM BY AN NF-kappaB INDUCER AND AN ANTIGEN |
| 04/02/2008 | EP1087993B1 Fas peptides and antibodies for modulating apoptosis |
| 04/02/2008 | EP0822985B1 Variable fragments of immunoglobulins - use for therapeutic or veterinary purposes |
| 04/02/2008 | EP0822830B1 Human anti-IL-8 antibodies, derived from immunized xenomice |
| 04/02/2008 | EP0666911B1 Multidrug resistance gene |
| 04/02/2008 | CN101155932A Anti-egfr antibody therapy based on an increased copy number of the egfr gene in tumor tissues |
| 04/02/2008 | CN101155832A 抗体的改良方法 Improved methods of antibody |
| 04/02/2008 | CN101155831A Anti-interferon alpha monoclonal antibodies and methods for use |
| 04/02/2008 | CN101155830A Antibodies that bind to epha2 and methods of use thereof |
| 04/02/2008 | CN101155827A HIV resistance genes |
| 04/02/2008 | CN101155601A Bioactive stents for type ii diabetics and methods for use thereof |
| 04/02/2008 | CN101152574A Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome |
| 04/02/2008 | CN101152573A Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome |
| 04/02/2008 | CN100378223C Pylorus screw bacterium fenestra element having adhesion function |
| 04/02/2008 | CN100378222C Enhanced 2-keto-L-gulonic acid production |
| 04/02/2008 | CN100378127C Antibodies against insulin-like growth factor I receptor and application thereof |
| 04/02/2008 | CN100378124C Hsp70 from arthrobacter |
| 04/02/2008 | CN100378121C Isolated peptides corresponding to amino acid sequences of NY-ESO-1, wherein bind to MHC class I and MHC class II molecules, and uses thereof |
| 04/01/2008 | US7351816 Nucleic acid encoding anti-IgE antibodies |
| 04/01/2008 | US7351810 Polypeptides, polynucleotides and uses thereof |
| 04/01/2008 | US7351807 Cyanine-sulfenates for dual phototherapy |
| 04/01/2008 | US7351805 Immunoglobulin for diagnosing and prognosticating human cancer |
| 04/01/2008 | US7351804 Antibodies against PRO4421 |
| 04/01/2008 | US7351803 CD16A binding proteins and use for the treatment of immune disorders |
| 04/01/2008 | US7351802 For stimulating release of tumor necrosis factor, and/or cellular proliferation/differentiation of chondrocytes by contacting blood with pro-polypeptides; cancer diagnosis |
| 04/01/2008 | US7351801 Using cation exchange on a bimodal high salt tolerant matrix to isolate/recover human serum albumin from cell culture supernatant |
| 04/01/2008 | US7351794 PRO1754 polypeptides |
| 04/01/2008 | US7351793 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and tumor disorders |
| 04/01/2008 | US7351789 For pharmaceuticals, diagnostics, biosensors and bioreactors |
| 04/01/2008 | US7351694 Diagnosis of prostate cancer; genetic engineered protein |
| 04/01/2008 | US7351693 Peptides and nucleic acids of the cathelicidin family, derived from fish, and uses thereof |
| 04/01/2008 | US7351555 Expression vector comprising nucleotide sequences coding cytokine receptor (Zcytor16) for use as antagonist tool of interleukin-10 related t-cell derived inducible factor in diagnosis, treatment and prevention of cell proliferative and inflammatory disorders |
| 04/01/2008 | US7351554 Administering vaccine, native E7 protein, inactive fragment of the immunosuppressive and/or angiogenic native E7 protein;a DNA molecule encoding immunosuppressive and/or angiogenic native E7 protein inactivated by mutation; adjuvant of mucosal immunity |
| 04/01/2008 | US7351526 Using configuration changes/variations in protein as diagnostic/prognostic indicator of spongiform and nervous system disorders |
| 04/01/2008 | US7351435 Detoxification of ricin by complexing with antibodies |
| 04/01/2008 | CA2341240C Autoantibody inhibitors |
| 04/01/2008 | CA2305623C Porcine circovirus, vaccines, and diagnostic reagents |
| 03/27/2008 | WO2008036899A2 Methods for removing viral contaminants during protein purification |
| 03/27/2008 | WO2008035527A1 ANTI-C1q MONOCLONAL ANTIBODY |
| 03/27/2008 | WO2008035463A1 Antibody class switching method |
| 03/27/2008 | WO2008035343A2 Artificial receptors |
| 03/27/2008 | WO2008035217A2 Fusion proteins comprising two or more igg binding domains of streptococcal protein g. |
| 03/27/2008 | WO2008034648A1 Process for the production of a fine chemical |
| 03/27/2008 | WO2008034181A1 ANTI-CANCER ANTIBODIES AGAINST LEWISy AND LEWISb ANTIGENS |
| 03/27/2008 | WO2008011519A3 Amigo-2 inhibitors for treating, diagnosing or detecting cancer |
| 03/27/2008 | WO2008005621A3 Compositions and methods for modulating immune responses |
| 03/27/2008 | WO2007149550A3 Modulation of differentiation and cell function via fox01 and notch signaling |
| 03/27/2008 | WO2007141274A3 Human binding molecules having killing activity against staphylococci and uses thereof |